Management of myocardial dysfunction in severe sepsis

Seminars in Respiratory and Critical Care Medicine

Volumn 32, Issue 2, 2011, Pages 206-214

  Jozwiak, Mathieu ^a   Persichini, Romain ^a   Monnet, Xavier ^a,b   Teboul, Jean Louis ^a,b  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

B type natriuretic peptide; dobutamine; echocardiography; levosimendan; myocardial depression; Sepsis

Indexed keywords

ADRENALIN; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM; DOBUTAMINE; LEVOSIMENDAN; MILRINONE; NITRIC OXIDE; NORADRENALIN; PEROXYNITRITE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TROPONIN;

APOPTOSIS; ARTICLE; CORONARY ARTERY BLOOD FLOW; DRUG EFFICACY; DRUG TOLERANCE; ECHOCARDIOGRAPHY; HEART DISEASE; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FAILURE; HUMAN; MYOCARDIAL DISEASE; MYOFILAMENT; PRIORITY JOURNAL; PULMONARY ARTERY CATHETER; SEPSIS; SEPTIC SHOCK;

ANIMALS; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CARDIOTONIC AGENTS; CATHETERIZATION, SWAN-GANZ; DOBUTAMINE; ECHOCARDIOGRAPHY; HUMANS; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; THERMODILUTION;

EID: 79955051940     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0031-1275533     Document Type: Article

References (60)

1. Dellinger R P., Levy M M., Carlet J M. et al, International Surviving Sepsis Campaign Guidelines Committee American Association of Critical-Care Nurses American College of Chest Physicians American College of Emergency Physicians Canadian Critical Care Society European Society of Clinical Microbiology and Infectious Diseases European Society of Intensive Care Medicine European Respiratory Society International Sepsis Forum Japanese Association for Acute Medicine Japanese Society of Intensive Care Medicine Society of Critical Care Medicine Society of Hospital Medicine Surgical Infection Society World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008 36 1 296-327
2. Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med 2008 36 6 1701-1706
3. Parker M M., Shelhamer J H., Bacharach S L. et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984 100 4 483-490 (Pubitemid 14126735)
4. Parrillo J E. Pathogenetic mechanisms of septic shock. N Engl J Med 1993 328 20 1471-1477
5. Zanotti Cavazzoni S L., Guglielmi M, Parrillo J E., Walker T, Dellinger R P., Hollenberg S M. Ventricular dilation is associated with improved cardiovascular performance and survival in sepsis. Chest 2010 138 4 848-855
6. Bouhemad B, Nicolas-Robin A, Arbelot C, Arthaud M, Féger F, Rouby J J. Acute left ventricular dilatation and shock-induced myocardial dysfunction. Crit Care Med 2009 37 2 441-447
7. Jardin F, Fourme T, Page B et al. Persistent preload defect in severe sepsis despite fluid loading: a longitudinal echocardiographic study in patients with septic shock. Chest 1999 116 5 1354-1359 (Pubitemid 29535992)
8. Poelaert J, Declerck C, Vogelaers D, Colardyn F, Visser C A. Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 1997 23 5 553-560 (Pubitemid 27263068)
9. Bouhemad B, Nicolas-Robin A, Arbelot C, Arthaud M, Féger F, Rouby J J. Isolated and reversible impairment of ventricular relaxation in patients with septic shock. Crit Care Med 2008 36 3 766-774
10. Etchecopar-Chevreuil C, François B, Clavel M, Pichon N, Gastinne H, Vignon P. Cardiac morphological and functional changes during early septic shock: a transesophageal echocardiographic study. Intensive Care Med 2008 34 2 250-256
11. Parker M M., McCarthy K E., Ognibene F P., Parrillo J E. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990 97 1 126-131 (Pubitemid 20023505)
12. Vieillard Baron A, Schmitt J M., Beauchet A et al. Early preload adaptation in septic shock? A transesophageal echocardiographic study. Anesthesiology 2001 94 3 400-406 (Pubitemid 32198445)
13. Rabuel C, Mebazaa A. Septic shock: a heart story since the 1960s. Intensive Care Med 2006 32 6 799-807 (Pubitemid 43781360)
14. Hunter J D., Doddi M. Sepsis and the heart. Br J Anaesth 2010 104 1 3-11
15. Cunnion R E., Schaer G L., Parker M M., Natanson C, Parrillo J E. The coronary circulation in human septic shock. Circulation 1986 73 4 637-644 (Pubitemid 16081421)
16. Dhainaut J F., Huyghebaert M F., Monsallier J F. et al. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 1987 75 3 533-541 (Pubitemid 17026042)
17. Lamia B, Chemla D, Richard C, Teboul J L. Clinical review: interpretation of arterial pressure wave in shock states. Crit Care 2005 9 6 601-606 (Pubitemid 43174470)
18. Lefer A M. Role of a myocardial depressant factor in the pathogenesis of circulatory shock. Fed Proc 1970 29 6 1836-1847
19. Parrillo J E., Burch C, Shelhamer J H., Parker M M., Natanson C, Schuette W. A circulating myocardial depressant substance in humans with septic shock: septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985 76 4 1539-1553 (Pubitemid 16193573)
20. Kumar A, Kumar A, Paladugu B, Mensing J, Parrillo J E. Transforming growth factor-beta1 blocks in vitro cardiac myocyte depression induced by tumor necrosis factor-alpha, interleukin-1beta, and human septic shock serum. Crit Care Med 2007 35 2 358-364 (Pubitemid 46148522)
21. Chensue S W., Terebuh P D., Remick D G., Scales W E., Kunkel S L. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia: kinetics, Kupffer cell expression, and glucocorticoid effects. Am J Pathol 1991 138 2 395-402
22. Abi-Gerges N, Tavernier B, Mebazaa A et al. Sequential changes in autonomic regulation of cardiac myocytes after in vivo endotoxin injection in rat. Am J Respir Crit Care Med 1999 160 4 1196-1204 (Pubitemid 29487459)
23. Tavernier B, Li J M., El-Omar M M. et al. Cardiac contractile impairment associated with increased phosphorylation of troponin I in endotoxemic rats. FASEB J 2001 15 2 294-296
24. Reithmann C, Hallström S, Pilz G, Kapsner T, Schlag G, Werdan K. Desensitization of rat cardiomyocyte adenylyl cyclase stimulation by plasma of noradrenaline-treated patients with septic shock. Circ Shock 1993 41 1 48-59 (Pubitemid 23267730)
25. Silverman H J., Penaranda R, Orens J B., Lee N H. Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines. Crit Care Med 1993 21 1 31-39 (Pubitemid 23028473)
26. Tang C, Liu M S. Initial externalization followed by internalization of beta-adrenergic receptors in rat heart during sepsis. Am J Physiol 1996 270 1 Pt 2 R254-R263
27. Kumar A, Paladugu B, Mensing J, Kumar A, Parrillo J E. Nitric oxide-dependent and -independent mechanisms are involved in TNF-alpha -induced depression of cardiac myocyte contractility. Am J Physiol Regul Integr Comp Physiol 2007 292 5 R1900-R1906 (Pubitemid 46708545)
28. Vona-Davis L, Wearden P, Hill J, Hill R. Cardiac response to nitric oxide synthase inhibition using aminoguanidine in a rat model of endotoxemia. Shock 2002 17 5 404-410
29. Lancel S, Tissier S, Mordon S et al. Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats. J Am Coll Cardiol 2004 43 12 2348-2358 (Pubitemid 38757609)
30. Ahmad R, Rasheed Z, Ahsan H. Biochemical and cellular toxicology of peroxynitrite: implications in cell death and autoimmune phenomenon. Immunopharmacol Immunotoxicol 2009 31 3 388-396
31. Carlson D L., Willis M S., White D J., Horton J W., Giroir B P. Tumor necrosis factor-alpha-induced caspase activation mediates endotoxin-related cardiac dysfunction. Crit Care Med 2005 33 5 1021-1028 (Pubitemid 40638175)
32. Nevière R, Fauvel H, Chopin C, Formstecher P, Marchetti P. Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care Med 2001 163 1 218-225 (Pubitemid 32095273)
33. Vieillard-Baron A. Assessment of right ventricular function. Curr Opin Crit Care 2009 15 3 254-260
34. Combes A, Berneau J B., Luyt C E., Trouillet J L. Estimation of left ventricular systolic function by single transpulmonary thermodilution. Intensive Care Med 2004 30 7 1377-1383 (Pubitemid 38951721)
35. Jabot J, Monnet X, Bouchra L, Chemla D, Richard C, Teboul J L. Cardiac function index provided by transpulmonary thermodilution behaves as an indicator of left ventricular systolic function. Crit Care Med 2009 37 11 2913-2918
36. Charpentier J, Luyt C E., Fulla Y et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004 32 3 660-665 (Pubitemid 38340060)
37. Brueckmann M, Huhle G, Lang S et al. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 2005 112 4 527-534 (Pubitemid 41060793)
38. Maeder M, Fehr T, Rickli H, Ammann P. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 2006 129 5 1349-1366
39. Ma K K., Ogawa T, de Bold A J. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 2004 36 4 505-513 (Pubitemid 38469941)
40. Pirracchio R, Deye N, Lukaszewicz A C. et al. Impaired plasma B-type natriuretic peptide clearance in human septic shock. Crit Care Med 2008 36 9 2542-2546
41. Fernandes C J. Jr, Akamine N, Knobel E. Cardiac troponin: a new serum marker of myocardial injury in sepsis. Intensive Care Med 1999 25 10 1165-1168 (Pubitemid 29525077)
42. Rsj H, Varpula M, Hagve T A. et al, The FINNSEPSIS Study Group. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med 2011 37 1 77-85
43. Ammann P, Maggiorini M, Bertel O et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003 41 11 2004-2009 (Pubitemid 36677123)
44. Turner A, Tsamitros M, Bellomo R. Myocardial cell injury in septic shock. Crit Care Med 1999 27 9 1775-1780 (Pubitemid 29455103)
45. Merx M W., Weber C. Sepsis and the heart. Circulation 2007 116 7 793-802 (Pubitemid 47255997)
46. Hayes M A., Timmins A C., Yau E H., Palazzo M, Hinds C J., Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994 330 24 1717-1722 (Pubitemid 24171030)
47. Boyd J H., Forbes J, Nakada T A., Walley K R., Russell J A. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011 39 2 259-265
48. Monnet X, Teboul J L. Volume responsiveness. Curr Opin Crit Care 2007 13 5 549-553 (Pubitemid 47357456)
49. Rivers E, Nguyen B, Havstad S et al, Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001 345 19 1368-1377
50. Teboul J L., Mercat A, Lenique F, Berton C, Richard C. Value of the venous-arterial PCO2 gradient to reflect the oxygen supply to demand in humans: effects of dobutamine. Crit Care Med 1998 26 6 1007-1010 (Pubitemid 28272849)
51. Kumar A, Schupp E, Bunnell E, Ali A, Milcarek B, Parrillo J E. Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock. Crit Care 2008 12 2 R35
52. Barraud D, Faivre V, Damy T et al. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. Crit Care Med 2007 35 5 1376-1382 (Pubitemid 46642669)
53. Morelli A, De Castro S, Teboul J L. et al. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 2005 31 5 638-644 (Pubitemid 40684980)
54. Morelli A, Teboul J L., Maggiore S M. et al. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 2006 34 9 2287-2293 (Pubitemid 44260011)
55. Hamzaoui O, Georger J F., Monnet X et al. Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care 2010 14 4 R142
56. Annane D, Vignon P, Renault A et al, CATS Study Group. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 2007 370 9588 676-684 (Pubitemid 47299251)
57. Levy B, Bollaert P E., Charpentier C et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 1997 23 3 282-287 (Pubitemid 27129993)
58. Levy B, Mansart A, Bollaert P E., Franck P, Mallie J P. Effects of epinephrine and norepinephrine on hemodynamics, oxidative metabolism, and organ energetics in endotoxemic rats. Intensive Care Med 2003 29 2 292-300 (Pubitemid 36384420)
59. Duranteau J, Sitbon P, Teboul J L. et al. Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 1999 27 5 893-900 (Pubitemid 29266005)
60. Creagh-Brown B C., Quinlan G J., Evans T W., Burke-Gaffney A. The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target? Intensive Care Med 2010 36 10 1644-1656